Back to results
US 2013/0295099 A2Published application
N-linkedglycan compounds
AssigneeThe Governors of the University of Alberta
InventorsChristine SZYMANSKI, Harald NOTHAFT
Life of this patent
Estimating the term…
Abstract
An isolated or purified compound is provided, comprising A-GlcNAc[GlcNAc]-GalNAc-GalNAc-QuiNAc4NAc, wherein A is GlcNAc or Glc. There is further provided a vaccine based on such compound, having particular use to treat or prevent an infection caused by a Campylobacter organism. There is also provided an antibody or antisera against the compound, having particular use to diagnose the presence of an infection caused by a Campylobacter organism.
Claims14
An isolated or purified compound comprising A-GlcNAc[GlcNAc]-GalNAc-GalNAc-QuiNAc4NAc, wherein A is GlcNAc or Glc.
6-7. (canceled)
Dependencies are inferred from the claim text.